QuantLogix's current estimate for Valo Health, published 2026-09-27 — in line with the last disclosed round of $1.4B (2022-Q4).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$1.4B
2022-Q4
weight 0.07
How this price has held up
No round has priced for Valo Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Valo Health, 2026-09-27 (f0fc2aaa577eaeb3).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Valo Health going public?
No. Valo Health is private and has not filed to go public. There is no S-1 on file.
What is Valo Health's valuation in 2026?
Valo Health is valued at $1.4B as of 2022-Q4, set by its Series C ($100M, Oct 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Valo Health filed an S-1?
No public S-1 is on file for Valo Health.
How much has Valo Health raised?
Valo Health has raised $595M in total, most recently a Series C of $100M in Oct 2022.
Is Valo Health publicly traded — can you buy Valo Health stock?
No. Valo Health is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Valo Health on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Name-verified against lead sponsor "Valo Health, Inc." on ClinicalTrials.gov as of 2026-09-27. Verify on ClinicalTrials.gov ↗
Talent Signal
Hiring trend
▼ Hiring downtrend
-33% vs 2026-08
Open roles
2
via greenhouse
Product-build share
100%
engineering, research, product, design
Trajectory
strengthening
heavy product build — 100% of open roles are product-building functions (engineering/research/product) — 2 of 2 open roles are research.
Recent senior hire: 1 senior hire (CFO); open roles trending down.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Key Executive Moves
INRita KaleCFO · 2026-08-14
From trusted-source news extraction (deep-enrich pipeline); dates approximate publication, not effective date.
Staff Data Scientist, Computational BiologyStaff Data Scientist, Machine Learning in Epidemiology and Patient Data Products
Counted from Valo Health's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
BiotechnologyHealth CareInformation Technology
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q4. Refreshed quarterly.